- Report
- May 2025
- 50 Pages
Global
From €2449EUR$2,650USD£2,065GBP
Thymalfasin is a type of drug used to treat infectious diseases. It is a synthetic form of thymosin alpha-1, a naturally occurring peptide hormone found in the thymus gland. Thymalfasin is used to treat a variety of infections, including HIV, hepatitis B and C, and other viral infections. It is also used to treat bacterial infections, such as tuberculosis and leprosy. Thymalfasin works by stimulating the immune system to fight off the infection.
Thymalfasin is available in both injectable and oral forms. It is typically prescribed for short-term use, as long-term use can lead to side effects. Common side effects include nausea, vomiting, and diarrhea.
The thymalfasin market is a growing one, with many companies offering products. Some of the major players in the market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. Other companies include Bristol-Myers Squibb, Novartis, and AstraZeneca. These companies offer a variety of thymalfasin products, ranging from generic to branded versions. Show Less Read more